Holen Sie sich die Stockscreener-App
300.57
1.24%
-3.78
Handel nachbörslich:
300.76
0.19
+0.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CI?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$304.35
Offen:
$304.14
24-Stunden-Volumen:
897.63K
Relative Volume:
0.49
Marktkapitalisierung:
$80.28B
Einnahmen:
$261.22B
Nettoeinkommen (Verlust:
$5.40B
KGV:
16.41
EPS:
18.32
Netto-Cashflow:
$3.94B
1W Leistung:
+0.75%
1M Leistung:
+1.42%
6M Leistung:
-4.25%
1J Leistung:
-15.09%
1-Tages-Spanne:
$298.78
$304.14
1-Wochen-Bereich:
$298.00
$308.42
52-Wochen-Spanne:
$256.89
$370.82
Cigna Group Stock (CI) Company Profile
Firmenname
Cigna Group
Sektor
Branche
Telefon
(860) 226-6000
Adresse
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Vergleichen Sie CI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
300.74 | 79.63B | 261.22B | 5.40B | 3.94B | 18.32 |
|
UNH
Unitedhealth Group Inc
|
304.86 | 279.39B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
71.21 | 89.00B | 386.46B | 4.49B | 4.78B | 3.58 |
|
ELV
Elevance Health Inc
|
314.23 | 69.65B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
297.39 | 34.54B | 123.11B | 1.58B | 2.44B | 13.03 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-06 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-02-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-01-04 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-06-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-04-05 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-22 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-05-27 | Fortgesetzt | Bernstein | Mkt Perform |
| 2022-05-26 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-05-16 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-05-09 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-02-07 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-17 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-06 | Bestätigt | BofA Securities | Buy |
| 2021-08-06 | Bestätigt | Citigroup | Buy |
| 2021-08-06 | Bestätigt | Deutsche Bank | Buy |
| 2021-08-06 | Bestätigt | Jefferies | Buy |
| 2021-08-06 | Bestätigt | Mizuho | Buy |
| 2021-08-06 | Bestätigt | Oppenheimer | Outperform |
| 2021-08-06 | Bestätigt | Truist | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-08-06 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | Eingeleitet | UBS | Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-24 | Eingeleitet | Edward Jones | Buy |
| 2018-03-13 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-03-08 | Eingeleitet | Barclays | Overweight |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-11-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-06-12 | Eingeleitet | Credit Suisse | Outperform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
Alle ansehen
Cigna Group Aktie (CI) Neueste Nachrichten
Cigna Insider Stock Sales: A Window into Executive Liquidity and Corporate Governance - AInvest
Cigna Group's Q2 2025 Earnings: What to Expect - MSN
Cigna Group stock outperforms competitors on strong trading day - MarketWatch
$100 Invested In Cigna Group 15 Years Ago Would Be Worth This Much Today - 富途牛牛
AI Trend Models Suggest Bounce for The Cigna GroupJuly 2025 Levels & Fast Exit Strategy with Risk Control - sundaytimes.kr
Could Easing Medicare Advantage Rules Reshape Cigna’s (CI) Competitive Edge in Healthcare Innovation? - simplywall.st
What’s the outlook for The Cigna Group’s sectorJuly 2025 PostEarnings & Weekly Momentum Picks - thegnnews.com
Is The Cigna Group a strong candidate for buy and holdIPO Watch & Daily Technical Forecast Reports - newsyoung.net
Cigna: Market Pessimism Creates Value Opportunity - Seeking Alpha
Cigna Group stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Cigna Group's Q2 2025 Earnings: Strategic Reinvention and the Road to Resilience - AInvest
Cigna Group shares rise 1.33% premarket after Baird raised its price target to $372. - AInvest
Health Insurance Providers Stocks Q2 Recap: Benchmarking Cigna (NYSE:CI) - Yahoo Finance
Stock Analysis | The Cigna OutlookNavigating Volatility Amid Mixed Signals - AInvest
Cigna Group shares rise 1.83% after-hours as Wells Fargo raises price target to $340. - AInvest
Baird Adjusts Cigna Group Price Target to $372 From $364 - MarketScreener
Wells Fargo Adjusts Price Target on Cigna Group to $340 From $341, Maintains Equalweight Rating - MarketScreener
MARPAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS - Benzinga
Ballad And Cigna Reach In-Network Agreement - GreenevilleSun.com
Raising Our Uncertainty Ratings on Cigna and Elevance on Medical Utilization and Regulatory Concerns - Morningstar
Uncertainty Rising at Cigna Primarily on Risks to Its PBM Operations - Morningstar
Do Wall Street Analysts Like Cigna Group Stock? - Yahoo Finance
How Aetna, Cigna, UnitedHealth stacked up in Q2 earnings - Modern Healthcare
What makes The Cigna Group stock price move sharplyHigh Impact Investment Signals - thegnnews.com
Cigna's 226th-Ranked Trading Volume Contrasts With High-Liquidity Stocks' Outperformance in Volatile Markets - AInvest
Earnings Surge and Major Buybacks Could Be a Game Changer for Cigna Group (CI) - simplywall.st
iTournament: Empowering employees to drive innovation at The Cigna Group - The Cigna Group Newsroom
Integrated medical, dental, and behavioral health treatment can lead to better health outcomes - Cigna Healthcare Newsroom
Cigna (CI) Pullback a Buying Opportunity, Says TD Cowen with a Buy Rating - MSN
What Cigna Group (CI)'s Strong Q2 Earnings and Share Buyback Reveal About Shareholder Value - simplywall.st
A transformative journey across the Midwest: Suzan Brydon’s Community Ambassador Fellowship story - The Cigna Group Newsroom
1 Safe-and-Steady Stock to Target This Week and 2 We Avoid - TradingView
We Think Cigna Group's (NYSE:CI) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance
Cigna’s Growth Story Comes With Margin Worries Attached - Finimize
J.P. Morgan Maintains Cigna Group(CI.US) With Buy Rating, Announces Target Price $428 - 富途牛牛
Cigna vs. UnitedHealth Group: Why Cigna Offers a More Attractive Value-Driven Investment in the Health Care Providers & Services Sector - AInvest
Cigna: Looks More Interesting Here Than UnitedHealth Group (NYSE:CI) - Seeking Alpha
Wall Street sours on health insurance - Modern Healthcare
Bert Nash cancels its contract with insurer Cigna; 121 patients could be affected - Lawrence Journal-World
Cigna (CI) Surges 2.2% on Strategic Expansion and Analyst Optimism: Is This the Start of a Bullish Rebound? - AInvest
Does Cigna Group's (CI) Margin Pressure Challenge Its Long-Term Growth Narrative? - simplywall.st
Cigna Expands Flexible Dental Payment Solution to 2.8 Million More Members, Driving Increases in Preventive Care and Critical Procedures - AInvest
Skipping the Dentist? Not Anymore: Cigna Expands Access to Flexible Dental Payments, Driving Meaningful Increases in Preventive Care and Critical Procedures - Nasdaq
Deutsche Bank Adjusts Cigna Group Price Target to $415 From $372, Maintains Buy Rating - MarketScreener
Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes - MSN
Cigna's $660M Volume Falls 26.2% to 150th Market Rank as Shares Rise 1.66% on Strategic Shifts and Expanded Partnerships - AInvest
Elevated Medicare Advantage, ACA marketplace costs sting insurers in mixed Q2 - Fierce Healthcare
Guggenheim Maintains Cigna Group(CI.US) With Buy Rating, Cuts Target Price to $350 - 富途牛牛
Elite Investors see life in Cigna - Citywire
The Cigna Group Stock Analysis and ForecastCapitalize on momentum-driven opportunities - Jammu Links News
Is The Cigna Group a good long term investmentMaximize portfolio growth with strategic plans - Jammu Links News
Finanzdaten der Cigna Group-Aktie (CI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):